4.7 Article

Structure based prediction of subtype-selectivity for adenosine receptor antagonists

期刊

NEUROPHARMACOLOGY
卷 60, 期 1, 页码 108-115

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuropharm.2010.07.009

关键词

GPCR; G protein-coupled receptor; Adenosine receptor; Subtype selectivity; Homology modeling; Ligand docking; Conformational sampling; Structure based drug discovery

资金

  1. National Institutes of Health [R01-GM071872, 1R43MH084374-01A1]
  2. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074832, R01GM071872] Funding Source: NIH RePORTER
  3. NATIONAL INSTITUTE OF MENTAL HEALTH [R43MH084374] Funding Source: NIH RePORTER

向作者/读者索取更多资源

One of the major hurdles in the development of safe and effective drugs targeting G-protein coupled receptors (GPCRs) is finding ligands that are highly selective for a specific receptor subtype. Structural understanding of subtype-specific binding pocket variations and ligand receptor interactions may greatly facilitate design of selective ligands. To gain insights into the structural basis of ligand subtype selectivity within the family of adenosine receptors (AR: A(1), A(2A), A(2B), and A(3)) we generated 3D models of all four subtypes using the recently determined crystal structure of the A(A2)AR as a template, and employing the methodology of ligand-guided receptor optimization for refinement. This approach produced 3D conformational models of AR subtypes that effectively explain binding modes and subtype selectivity for a diverse set of known AR antagonists. Analysis of the subtype-specific ligand receptor interactions allowed identification of the major determinants of ligand selectivity, which may facilitate discovery of more efficient drug candidates. (C) 2010 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据